183 related articles for article (PubMed ID: 29394931)
1. Fitting NTCP models to bladder doses and acute urinary symptoms during post-prostatectomy radiotherapy.
Mavroidis P; Pearlstein KA; Dooley J; Sun J; Saripalli S; Das SK; Wang AZ; Chen RC
Radiat Oncol; 2018 Feb; 13(1):17. PubMed ID: 29394931
[TBL] [Abstract][Full Text] [Related]
2. Dose-volume toxicity modeling for de-intensified chemo-radiation therapy for HPV-positive oropharynx cancer.
Mavroidis P; Price A; Fried D; Kostich M; Amdur R; Mendenhall W; Liu C; Das S; Marks LB; Chera B
Radiother Oncol; 2017 Aug; 124(2):240-247. PubMed ID: 28712533
[TBL] [Abstract][Full Text] [Related]
3. Fitting NTCP models to SBRT dose and carotid blowout syndrome data.
Mavroidis P; Grimm J; Cengiz M; Das S; Tan X; Yazici G; Ozyigit G
Med Phys; 2018 Oct; 45(10):4754-4762. PubMed ID: 30102783
[TBL] [Abstract][Full Text] [Related]
4. Normal tissue complication probability (NTCP) models of acute urinary toxicity (AUT) following carbon ion radiotherapy (CIRT) for prostate cancer.
Li Y; Li P; Hsi W; Hong Z; Fu S; Zhang Q
Radiother Oncol; 2021 Mar; 156():69-79. PubMed ID: 33309999
[TBL] [Abstract][Full Text] [Related]
5. Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.
D'Avino V; Palma G; Liuzzi R; Conson M; Doria F; Salvatore M; Pacelli R; Cella L
Radiat Oncol; 2015 Apr; 10():80. PubMed ID: 25890376
[TBL] [Abstract][Full Text] [Related]
6. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the clinical impact of the differences between planned and delivered dose in prostate cancer radiotherapy based on CT-on-rails IGRT and patient-reported outcome scores.
Hammers J; Lindsay D; Narayanasamy G; Sud S; Tan X; Dooley J; Marks LB; Chen RC; Das SK; Mavroidis P
J Appl Clin Med Phys; 2023 Jan; 24(1):e13780. PubMed ID: 36087039
[TBL] [Abstract][Full Text] [Related]
8. Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126.
Moore KL; Schmidt R; Moiseenko V; Olsen LA; Tan J; Xiao Y; Galvin J; Pugh S; Seider MJ; Dicker AP; Bosch W; Michalski J; Mutic S
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):228-35. PubMed ID: 25847605
[TBL] [Abstract][Full Text] [Related]
9. Normal tissue complication probability models for severe acute radiological lung injury after radiotherapy for lung cancer.
Avanzo M; Trovo M; Furlan C; Barresi L; Linda A; Stancanello J; Andreon L; Minatel E; Bazzocchi M; Trovo MG; Capra E
Phys Med; 2015 Feb; 31(1):1-8. PubMed ID: 25455442
[TBL] [Abstract][Full Text] [Related]
10. Rectal and Urethro-Vesical Subregions for Toxicity Prediction After Prostate Cancer Radiation Therapy: Validation of Voxel-Based Models in an Independent Population.
Mylona E; Ebert M; Kennedy A; Joseph D; Denham J; Steigler A; Supiot S; Acosta O; de Crevoisier R
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1189-1195. PubMed ID: 32673785
[TBL] [Abstract][Full Text] [Related]
11. Predictive modelling for late rectal and urinary toxicities after prostate radiotherapy using planned and delivered dose.
Ong ALK; Knight K; Panettieri V; Dimmock M; Tuan JKL; Tan HQ; Wright C
Front Oncol; 2022; 12():1084311. PubMed ID: 36591496
[TBL] [Abstract][Full Text] [Related]
12. Normal Tissue Complication Probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A Test of the QUANTEC-recommended NTCP model.
Liu M; Moiseenko V; Agranovich A; Karvat A; Kwan W; Saleh ZH; Apte AA; Deasy JO
Acta Oncol; 2010 Oct; 49(7):1040-4. PubMed ID: 20831493
[TBL] [Abstract][Full Text] [Related]
13. Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head.
Raturi VP; Hojo H; Hotta K; Baba H; Takahashi R; Rachi T; Nakamura N; Zenda S; Motegi A; Tachibana H; Ariji T; Motegi K; Nakamura M; Okumura M; Hirano Y; Akimoto T
Radiat Oncol; 2020 Jun; 15(1):157. PubMed ID: 32571379
[TBL] [Abstract][Full Text] [Related]
14. Normal tissue complication probability modeling to guide individual treatment planning in pediatric cranial proton and photon radiotherapy.
Dell'Oro M; Wilson P; Short M; Hua CH; Merchant TE; Bezak E
Med Phys; 2022 Jan; 49(1):742-755. PubMed ID: 34796509
[TBL] [Abstract][Full Text] [Related]
15. NTCP modeling and dose-volume correlations for acute xerostomia and dry eye after whole brain radiation.
Mavroidis P; Pearlstein KA; Moon DH; Xu V; Royce TJ; Weiner AA; Shen CJ; Marks LB; Chera BS; Das SK; Wang K
Radiat Oncol; 2021 Mar; 16(1):56. PubMed ID: 33743773
[TBL] [Abstract][Full Text] [Related]
16. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
Luxton G; Hancock SL; Boyer AL
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
[TBL] [Abstract][Full Text] [Related]
17. Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.
Deville C; Vapiwala N; Hwang WT; Lin H; Ad VB; Tochner Z; Both S
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1389-96. PubMed ID: 21664069
[TBL] [Abstract][Full Text] [Related]
18. Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer.
Cheung MR; Tucker SL; Dong L; de Crevoisier R; Lee AK; Frank S; Kudchadker RJ; Thames H; Mohan R; Kuban D
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1059-65. PubMed ID: 17241755
[TBL] [Abstract][Full Text] [Related]
19. Complication probability models for radiation-induced heart valvular dysfunction: do heart-lung interactions play a role?
Cella L; Palma G; Deasy JO; Oh JH; Liuzzi R; D'Avino V; Conson M; Pugliese N; Picardi M; Salvatore M; Pacelli R
PLoS One; 2014; 9(10):e111753. PubMed ID: 25360627
[TBL] [Abstract][Full Text] [Related]
20. A treatment planning study comparing IMRT techniques and cyber knife for stereotactic body radiotherapy of low-risk prostate carcinoma.
Scobioala S; Kittel C; Elsayad K; Kroeger K; Oertel M; Samhouri L; Haverkamp U; Eich HT
Radiat Oncol; 2019 Aug; 14(1):143. PubMed ID: 31399115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
